Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $89.75 USD
Change Today +0.83 / 0.93%
Volume 202.6K
As of 8:10 PM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for ligand pharmaceuticals (LGND)

Year over year, Ligand Pharmaceuticals Incorporated has been able to grow revenues from $49.0M USD to $64.5M USD. Most impressively, the company has been able to reduce the percentage of sales devoted to selling, general and administrative costs from 36.72% to 34.97%. This was a driver that led to a bottom line growth from $11.4M USD to $12.0M USD.
Currency in
Millions of US Dollars
As of:Dec 31
2011
Restated
Dec 31
2012
Reclassified
Dec 31
2013
Dec 31
2014
4 Year
Trend
Revenues30.031.449.064.5
TOTAL REVENUES30.031.449.064.5
Cost of Goods Sold15.214.415.021.3
GROSS PROFIT14.817.034.043.3
Selling General & Admin Expenses, Total14.615.818.022.6
OTHER OPERATING EXPENSES, TOTAL14.615.818.022.6
OPERATING INCOME0.31.216.020.7
Interest Expense-2.3-2.9-2.1-4.9
NET INTEREST EXPENSE-2.3-2.9-2.1-4.9
Other Non-Operating Income (Expenses)0.20.5-0.10.1
EBT, EXCLUDING UNUSUAL ITEMS-1.9-1.213.816.0
Gain (Loss) on Sale of Investments------1.5
Gain (Loss) on Sale of Assets2.2------
Other Unusual Items, Total-3.8-2.7-4.6-6.2
In Process R&D Expenses-2.3---0.5--
Other Unusual Items-1.6-2.7-4.2-6.2
EBT, INCLUDING UNUSUAL ITEMS-3.6-3.99.211.3
Income Tax Expense-13.3-1.20.40.4
Minority Interest in Earnings------1.1
Earnings from Continuing Operations9.7-2.78.810.9
EARNINGS FROM DISCOUNTINUED OPERATIONS0.02.12.6--
NET INCOME9.7-0.511.412.0
NET INCOME TO COMMON INCLUDING EXTRA ITEMS9.7-0.511.412.0
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS9.7-2.78.812.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LGND:US $89.75 USD +0.83

LGND Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for LGND.
View Industry Companies
 

Industry Analysis

LGND

Industry Average

Valuation LGND Industry Range
Price/Earnings 100.0x
Price/Sales 27.6x
Price/Book 66.8x
Price/Cash Flow 146.6x
TEV/Sales 21.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LIGAND PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.